IDEXX Laboratories Announces Third Quarter Results
IDEXX Laboratories, Inc. (IDXX)
Last idexx laboratories, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
idexx.com/en/about-idexx/investors
Company Research
Source: Business Wire
Achieves third quarter revenue growth of 13% as reported and 12% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic.Strong organic revenue growth was supported by IDEXX execution and commercial performance, reflecting benefits from IDEXX's innovation, including over 1,700 IDEXX inVue Dx™ placements.Delivers EPS of $3.40, an increase of 21% as reported and 15% on a comparable basis, including operating margin expansion of 100 basis points as reported and 120 basis points on a comparable basis.Increases 2025 revenue guidance to $4,270 million - $4,300 million, an increase of $43 million or ~1% at midpoint, reflecting stronger CAG Diagnostics recurring revenue performance and outlook for higher IDEXX inVue Dx instrument placements and revenues.Updates outlook for 2025 reported revenue growth of 9.6% - 10.3% and CAG Diagnostics recurring revenue reported growth of 8.3% - 9.0%, with projected 2025 organic revenue growth of 8.8% - 9.5% and CAG Diagnosti
Show less
Read more
Impact Snapshot
Event Time:
IDXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDXX alerts
High impacting IDEXX Laboratories, Inc. news events
Weekly update
A roundup of the hottest topics
IDXX
News
- IDEXX Laboratories (IDXX): A Fresh Look at Valuation After Recent Momentum Shift [Yahoo! Finance]Yahoo! Finance
- IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=IDXX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StreMarketBeat
- Idexx (IDXX) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- IDEXX Laboratories (NASDAQ:IDXX) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- How the Story Around IDEXX Is Shifting With Strong Results and New Analyst Targets [Yahoo! Finance]Yahoo! Finance
IDXX
Earnings
- 11/3/25 - Beat
IDXX
Sec Filings
- 12/3/25 - Form 4
- 11/10/25 - Form 4
- 11/7/25 - Form 144
- IDXX's page on the SEC website